AUTH:"Goode EL" - Search results

Germline copy number variants and endometrial cancer risk.

Stylianou CE, Wiggins GAR, Lau VL, Dennis J, Shelling AN, Wilson M, Sykes P, Amant F, Annibali D, De Wispelaere W, Easton DF, Fasching PA, Glubb DM, Goode EL, Lambrechts D, Pharoah PDP, Scott RJ, Tham E, Tomlinson I, [...] Walker LC

Hum Genet, 04 Nov 2024

Cited by: 0 articles | PMID: 39495297

Add to export list

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer.

Nelson BH, Hamilton PT, Phung MT, Milne K, Harris B, Thornton S, Stevens DL, Kalaria S, Singh K, Laumont CM, Moss E, Alimujiang A, Meagher NS, Bolithon A, Fereday S, Kennedy CJ, Hendley J, Ariyaratne D, Alsop K, [...] Pearce CL

J Clin Invest, e179501, 29 Oct 2024

Cited by: 0 articles | PMID: 39470729

Add to export list

Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium.

Meagher NS, White KK, Wilkens LR, Bandera EV, Berchuck A, Carney ME, Cramer DW, Cushing-Haugen KL, Jordan S, Kaufmann SH, Le ND, Pike MC, Riggan M, Qin B, Rothstein JH, Titus L, Winham SJ, Anton-Culver H, Doherty JA, [...] Merritt MA

Am J Epidemiol, 193(9):1242-1252, 01 Sep 2024

Cited by: 0 articles | PMID: 38775277 | PMCID: PMC11369223

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Saner FAM, Takahashi K, Budden T, Pandey A, Ariyaratne D, Zwimpfer TA, Meagher NS, Fereday S, Twomey L, Pishas KI, Hoang T, Bolithon A, Traficante N, Australian Ovarian Cancer Study Group, Alsop K, Christie EL, Kang EY, Nelson GS, Ghatage P, [...] Garsed DW

Clin Cancer Res, 30(16):3481-3498, 01 Aug 2024

Cited by: 0 articles | PMID: 38837893 | PMCID: PMC11325151

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing.

Aglago EK, Qu C, Harlid S, Phipps AI, Steinfelder RS, Ogino S, Thomas CE, Hsu L, Toland AE, Brenner H, Berndt SI, Buchanan DD, Campbell PT, Cao Y, Chan AT, Drew DA, Figueiredo JC, French AJ, Gallinger S, [...] Peters U

Am J Clin Nutr, 120(3):664-673, 16 Jul 2024

Cited by: 0 articles | PMID: 39025327 | PMCID: PMC11393398

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.

Dareng EO, Coetzee SG, Tyrer JP, Peng PC, Rosenow W, Chen S, Davis BD, Dezem FS, Seo JH, Nameki R, Reyes AL, Aben KKH, Anton-Culver H, Antonenkova NN, Aravantinos G, Bandera EV, Beane Freeman LE, Beckmann MW, Beeghly-Fadiel A, [...] Gayther SA

Am J Hum Genet, 111(6):1061-1083, 08 May 2024

Cited by: 3 articles | PMID: 38723632

Add to export list

Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities.

Bateman NW, Abulez T, Soltis AR, McPherson A, Choi S, Garsed DW, Pandey A, Tian C, Hood BL, Conrads KA, Teng PN, Oliver J, Gist G, Mitchell D, Litzi TJ, Tarney CM, Crothers BA, Mhawech-Fauceglia P, Dalgard CL, [...] Maxwell GL

NPJ Precis Oncol, 8(1):97, 06 May 2024

Cited by: 0 articles | PMID: 38710993 | PMCID: PMC11074115

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Epidemiologic Factors in Relation to Colorectal Cancer Risk and Survival by Genotoxic Colibactin Mutational Signature.

Thomas CE, Georgeson P, Qu C, Steinfelder RS, Buchanan DD, Song M, Harrison TA, Um CY, Hullar MA, Jenkins MA, Van Guelpen B, Lynch BM, Melaku YA, Huyghe JR, Aglago EK, Berndt SI, Boardman LA, Campbell PT, Cao Y, [...] Phipps AI

Cancer Epidemiol Biomarkers Prev, 33(4):534-546, 01 Apr 2024

Cited by: 0 articles | PMID: 38252034 | PMCID: PMC10990777

Add to export list Free full text in Europe PMC

Risk Factors for Ovarian Cancer by BRCA Status: A Collaborative Case-Only Analysis.

Gersekowski K, Na R, Alsop K, Delahunty R, Goode EL, Cunningham JM, Winham SJ, Pharoah PDP, Song H, Webb PM

Cancer Epidemiol Biomarkers Prev, 33(4):586-592, 01 Apr 2024

Cited by: 0 articles | PMID: 38300121 | PMCID: PMC11268497

Add to export list Free full text in Europe PMC

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk

Barnes DR, Tyrer JP, Dennis J, Leslie G, Bolla MK, Lush M, Aeilts AM, Aittomäki K, Andrieu N, Andrulis IL, Anton-Culver H, Arason A, Arun BK, Balmaña J, Bandera EV, Barkardottir RB, Berger LP, Berrington de Gonzalez A, Berthet P, [...] Pharoah PD

medRxiv, 04 Mar 2024

Cited by: 0 articles | PPR: PPR816124

Add to export list Preprint

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities.

Bateman NW, Abulez T, Soltis AR, McPherson A, Choi S, Garsed DW, Pandey A, Tian C, Hood BL, Conrads KA, Teng PN, Oliver J, Gist G, Mitchell D, Litzi TJ, Tarney CM, Crothers BA, Mhawech-Fauceglia P, Dalgard CL, [...] Maxwell GL

NPJ Precis Oncol, 8(1):68, 13 Mar 2024

Cited by: 2 articles | PMID: 38480868 | PMCID: PMC10937683

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease.

Ramachandran D, Tyrer JP, Kommoss S, DeFazio A, Riggan MJ, AOCS Group, Webb PM, Fasching PA, Lambrechts D, García MJ, Rodríguez-Antona C, Goodman MT, Modugno F, Moysich KB, Karlan BY, Lester J, Kjaer SK, Jensen A, Høgdall E, [...] Heitz F

NPJ Genom Med, 9(1):19, 05 Mar 2024

Cited by: 0 articles | PMID: 38443389 | PMCID: PMC10915171

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Concurrent RB1 loss andBRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma

Saner FAM, Takahashi K, Budden T, Pandey A, Ariyaratne D, Zwimpfer TA, Meagher NS, Fereday S, Twomey L, Pishas KI, Hoang T, Bolithon A, Traficante N, Alsop K, Christie EL, Kang E, Nelson GS, Ghatage P, Lee C, [...] Garsed DW

medRxiv, 10 Nov 2023

Cited by: 0 articles | PPR: PPR757426

Add to export list Preprint

The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas.

Heinze K, Cairns ES, Thornton S, Harris B, Milne K, Grube M, Meyer C, Karnezis AN, Fereday S, Garsed DW, Leung SCY, Chiu DS, Moubarak M, Harter P, Heitz F, McAlpine JN, DeFazio A, Bowtell DDL, Goode EL, [...] Anglesio MS

Clin Cancer Res, 29(17):3471-3483, 01 Sep 2023

Cited by: 3 articles | PMID: 37339172 | PMCID: PMC10472107

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Batch-effect correction with sample remeasurement in highly confounded case-control studies.

Ye H, Zhang X, Wang C, Goode EL, Chen J

Nat Comput Sci, 3(8):709-719, 23 Aug 2023

Cited by: 1 article | PMID: 38177326

Add to export list

Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.

Fu Z, Brooks MM, Irvin S, Jordan S, Aben KKH, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Brooks-Wilson A, Chang-Claude J, Cook LS, Cramer DW, Cushing-Haugen KL, Doherty JA, Ekici AB, Fasching PA, Fortner RT, Gayther SA, [...] Modugno F

J Natl Cancer Inst, 115(5):539-551, 01 May 2023

Cited by: 9 articles | PMID: 36688720 | PMCID: PMC10165492

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.

May T, Bernardini M, Lheureux S, Aben KKH, Bandera EV, Beckmann MW, Benitez J, Berchuck A, Bjørge L, Carney ME, Cramer DW, deFazio A, Dörk T, Eccles DM, Friedlander M, García MJ, Goode EL, Hein A, Høgdall CK, [...] Ovarian Cancer Association and the Australian Ovarian Cancer Study Group

Can J Surg, 66(3):E310-E320, 01 May 2023

Cited by: 0 articles | PMID: 37369443 | PMCID: PMC10310341

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma.

Wang C, Block MS, Cunningham JM, Sherman ME, McCauley BM, Armasu SM, Vierkant RA, Traficante N, Australian Ovarian Cancer Study Group, Talhouk A, Ramus SJ, Pejovic N, Köbel M, Jorgensen BD, Garsed DW, Fereday S, Doherty JA, Ariyaratne D, Anglesio MS, [...] Goode EL

Cancer Epidemiol Biomarkers Prev, 32(4):542-549, 01 Apr 2023

Cited by: 0 articles | PMID: 36790339 | PMCID: PMC10073286

Add to export list Free full text in Europe PMC

Multi-trait genome-wide association study identifies a novel endometrial cancer risk locus that associates with testosterone levels.

Wang X, Kho PF, Ramachandran D, Bafligil C, Amant F, Goode EL, Scott RJ, Tomlinson I, Evans DG, Crosbie EJ, Dörk T, Spurdle AB, Glubb DM, O'Mara TA

iScience, 26(5):106590, 07 Apr 2023

Cited by: 2 articles | PMID: 37168552 | PMCID: PMC10165198

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.

Köbel M, Kang EY, Weir A, Rambau PF, Lee CH, Nelson GS, Ghatage P, Meagher NS, Riggan MJ, Alsop J, Anglesio MS, Beckmann MW, Bisinotto C, Boisen M, Boros J, Brand AH, Brooks-Wilson A, Carney ME, Coulson P, [...] Brenton JD

J Pathol Clin Res, 9(3):208-222, 22 Mar 2023

Cited by: 4 articles | PMID: 36948887 | PMCID: PMC10073933

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival

Georgeson P, Steinfelder RS, Harrison TA, Pope BJ, Zaidi SH, Qu C, Lin Y, Joo JE, Mahmood K, Clendenning M, Walker R, Aglago EK, Berndt SI, Brenner H, Campbell PT, Cao Y, Chan AT, Chang-Claude J, Dimou N, [...] Buchanan DD

medRxiv, 12 Mar 2023

Cited by: 0 articles | PPR: PPR629033

Add to export list Preprint

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.

Kang EY, Weir A, Meagher NS, Farrington K, Nelson GS, Ghatage P, Lee CH, Riggan MJ, Bolithon A, Popovic G, Leung B, Tang K, Lambie N, Millstein J, Alsop J, Anglesio MS, Ataseven B, Barlow E, Beckmann MW, [...] Köbel M

Cancer, 129(5):697-713, 26 Dec 2022

Cited by: 9 articles | PMID: 36572991 | PMCID: PMC10107112

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.

Garsed DW, Pandey A, Fereday S, Kennedy CJ, Takahashi K, Alsop K, Hamilton PT, Hendley J, Chiew YE, Traficante N, Provan P, Ariyaratne D, Au-Yeung G, Bateman NW, Bowes L, Brand A, Christie EL, Cunningham JM, Friedlander M, [...] Bowtell DDL

Nat Genet, 54(12):1853-1864, 01 Dec 2022

Cited by: 29 articles | PMID: 36456881 | PMCID: PMC10478425

Add to export list Free full text in Europe PMC

Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery.

Phung MT, Webb PM, DeFazio A, Fereday S, Lee AW, Bowtell DDL, Fasching PA, Goode EL, Goodman MT, Karlan BY, Lester J, Matsuo K, Modugno F, Brenton JD, Van Gorp T, Pharoah PDP, Schildkraut JM, McLean K, Meza R, [...] Ovarian Cancer Association Consortium

Gynecol Oncol, 168:68-75, 17 Nov 2022

Cited by: 0 articles | PMID: 36401943 | PMCID: PMC10398872

Add to export list Free full text in Europe PMC

Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.

Bolton KL, Chen D, Corona de la Fuente R, Fu Z, Murali R, Köbel M, Tazi Y, Cunningham JM, Chan ICC, Wiley BJ, Moukarzel LA, Winham SJ, Armasu SM, Lester J, Elishaev E, Laslavic A, Kennedy CJ, Piskorz A, Sekowska M, [...] Papaemmanuil E

Clin Cancer Res, 28(22):4947-4956, 01 Nov 2022

Cited by: 20 articles | PMID: 35816189 | PMCID: PMC9777703

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Germline copy number variants and endometrial cancer risk.

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer.

Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium.

Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing.

Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.

Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities.

Epidemiologic Factors in Relation to Colorectal Cancer Risk and Survival by Genotoxic Colibactin Mutational Signature.

Risk Factors for Ovarian Cancer by BRCA Status: A Collaborative Case-Only Analysis.

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk

Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities.

Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease.

Concurrent RB1 loss andBRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma

The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas.

Batch-effect correction with sample remeasurement in highly confounded case-control studies.

Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.

Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.

Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma.

Multi-trait genome-wide association study identifies a novel endometrial cancer risk locus that associates with testosterone levels.

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.

Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.

The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.

Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery.

Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.

Partnerships & funding